Phase 2 N=120 Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19
COVID-19
Primary: Duration Until Viral Shedding Cessation — 7; 7 days — p=0.29
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=59 RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers
Metastatic Cancers
Primary: Number of Adverse Events — 428 Adverse Events
N/A N=50 Clinical Comparison of Length of Cataract Procedures With Zeiss Lumera Versus Older Zeiss Microscope
Cataract
Primary: Improvement in Operating Room Efficiencies During Cataract Surgery With the Use of the New Lumera Operating Microscope Versus an Older Zeiss Model Operating Scope…
N/A N=200 Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina
Stable Angina
Primary: Exercise Time on Treadmill — 28.4; 11.8 seconds
Phase 1 N=20 Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC
Metastatic Colorectal Cancer · MSS
Primary: Feasibility Rate of a Combined Therapy — 18 Participants
Phase 2 N=21 Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Adenoid Cystic Carcinoma
Primary: Patients Demonstrating Objective Response In Non-Irradiated Lesions (Tumor Size on Scans) — 0; 0 Participants
N/A N=40 The Safety and Efficacy of a SinuSonic Intervention
Nasal Congestion
Primary: Change in Total Nasal Symptom Score (TNSS) at 4 to 6 Weeks — 3.5 score on a scale
N/A N=53 Post Approval Study of the remedē System
Central Sleep Apnea
Primary: 5-Year Survival Rate — 78 percentage of participants
Phase 2 N=6 A Study to Assess the Safety and Tolerability of SOBI003 in Pediatric MPS IIIA Patients
Sanfilippo Syndrome Type A (MPS IIIA)
Primary: Safety as Measured by Adverse Events Frequencies (by Type and Severity) — 53; 128; 0; 1 number of events
N/A N=307 Crisis Line Facilitation
Suicide · Suicide, Attempted · Hospitals, Psychiatric
Primary: Number of Veterans Crisis Line (VCL) Contact Events Per Days at Risk — 48; 35 VCL Contact Events — p=0.33
N/A N=580 Family-centered Oral Health Promotion for New Parents
Dental Caries
Primary: Early Childhood Caries (ECC) — 8; 41 Participants
N/A N=174 High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
Adult Acute Lymphoblastic Leukemia in Remission · Adult Acute Myeloid Leukemia in Remission · Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Primary: Progression-free Survival (PFS) Distribution of Patients With HL, NHL, and MM for Each Disease-specific High-dose Therapy Regimen, Estimate Provided for 10-yr PFS…
N/A N=80 Comparison of Tesio and LifeCath Twin Permanent Dialysis Catheters
Hemodialysis
Primary: Blood Flow Rate at First Use After Insertion — 277; 383 mL/min
N/A N=40 Citicoline, Creatine, and Omega-3 Effects in Middle Age Women
Cognitive Benefits
Primary: Change From Baseline in California Verbal Learning Test (CVLT) That Measure Attention and Memory at 14 Days — 10 score on a scale
N/A N=254 Innovative Approaches for Minor Consent: Consent 2.0
HIV
Primary: Mean Adolescent WTP Scores — 3.7; 3.7; 3.5 score on a scale — p=0.5148